Peptide-Lab Partner Program
GLP-1 secretion targets (e.g., diabetes, obesity)
DiscoveryActive
Key Facts
Indication
GLP-1 secretion targets (e.g., diabetes, obesity)
Phase
Discovery
Status
Active
Company
About Metastate Metabolomics
Founded in 2019 and based in Zurich, Metastate Metabolomics has developed the 'Metastate Brain,' a decision system designed to compress uncertainty in expensive biological R&D. The company offers focused programs that help teams move from data overload to confident next steps, delivering ranked hypotheses and minimum experiment sets. Its business model is centered on project-based engagements rather than traditional software licenses, targeting high-stakes decisions in industrial biotech and diagnostics.
View full company profile